[1] POWERS W J，RABINSTEIN A A，ACKERSON

T，et al. 2018 guidelines for the early management of

patients with acute ischemic stroke：a guideline for

healthcare professionals from the American Heart

Association/American Stroke Association[J/OL].

Stroke，2018，49（3）：e46-e110[2021-01-20].

https：//doi.org/10.1161/STR.0000000000000158.

[2] MAAIJWEE N A，RUTTEN-JACOBS L

C，SCHAAPSMEERDERS P，et al. Ischaemic

stroke in young adults：risk factors and long-term

consequences[J]. Nat Rev Neurol，2014，10（6）：

315-325.

[3] PUTAALA J，METSO A J，METSO T M，et al.

Analysis of 1008 consecutive patients aged 15 to 49

with first-ever ischemic stroke：the Helsinki young

stroke registry[J]. Stroke，2009，40（4）：1195-1203.

[4] LEE V H，BROWN R D Jr，MANDREKAR J

N，et al. Incidence and outcome of cervical artery

dissection：a population-based study[J]. Neurology，

2006，67（10）：1809-1812.

[5] SPORNS P B，NIEDERSTADT T，HEINDEL

W，et al. Imaging of spontaneous and traumatic

cervical artery dissection：comparison of typical CT

angiographic features[J]. Clin Neuroradiol，2019，29

（2）：269-275.

[6] HAN M，RIM N J，LEE J S，et al. Feasibility of

high-resolution MR imaging for the diagnosis of

intracranial vertebrobasilar artery dissection[J]. Eur

Radiol，2014，24（12）：3017-3024.

[7] SMITH W S，JOHNSTON S C，SKALABRIN E J，

et al. Spinal manipulative therapy is an independent

risk factor for vertebral artery dissection[J].

Neurology，2003，60（9）：1424-1428.

[8] ZINKSTOK S M，VERGOUWEN M D，

ENGELTER S T，et al. Safety and functional

outcome of thrombolysis in dissection-related

ischemic stroke：a meta-analysis of individual

patient data[J]. Stroke，2011，42（9）：2515-2520.

[9] HOVING J W，MARQUERING H A，MAJOIE C B

L M. Endovascular treatment in patients with carotid

artery dissection and intracranial occlusion：a

systematic review[J]. Neuroradiology，2017，59（7）：

641-647.

[10] CHOWDHURY M M，SABBAGH C N，JACKSON

D，et al. Antithrombotic treatment for acute

extracranial carotid artery dissections：a metaanalysis[

J]. Eur J Vasc Endovasc Surg，2015，50（2）：

148-156.

[11] YAO X X，ABRAHAM N S，SANGARALINGHAM

L R，et al. Effectiveness and safety of

dabigatran，rivaroxaban，and apixaban versus

warfarin in nonvalvular atrial fibrillation[J/OL]. J

Am Heart Assoc，2016，5（6）：e003725[2021-01-20].

https：//doi.org/10.1161/JAHA.116.003725.